DCM
AMED

Delpha Capital Management’s Amedisys AMED Stock Holding History

Delpha Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-342
Closed -$18K – 177
2017
Q4 		$18K Buy
+342
New +$18K 0.02% 817

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Delpha Capital Management's AMED Position: Q1 2018 in Review

Delpha Capital Management sold out of Amedisys (AMED) in Q1 2018, closing a stake of 342 shares — an estimated $18K sold.

Delpha Capital Management first reported a position in AMED in Q4 2017 and held it in 1 quarter. The position peaked at $18K in Q4 2017. 194 funds tracked by Wall St. Rank hold AMED as of Q1 2018.

  • Delpha Capital Management reported no remaining Amedisys position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 342 Amedisys shares in Q1 2018, an estimated $18K.
  • Delpha Capital Management first reported a position in Amedisys in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Amedisys position peaked at $18K in Q4 2017.
  • 194 funds tracked by Wall St. Rank held Amedisys as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.